Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Navidea Biopharmaceuticals Inc    NAVB

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
04/21/2017 04/24/2017 04/25/2017 04/26/2017 04/27/2017 Date
0.4601(c) 0.4591(c) 0.5108(c) 0.521(c) 0.489(c) Last
522 398 490 999 983 679 616 101 451 628 Volume
+2.24% -0.22% +11.26% +2.00% -6.14% Change
More quotes
Company
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutic.It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and... 
More about the company
Latest news on NAVIDEA BIOPHARMACEUTICALS
04/25 NAVIDEA BIOPHARMACEUTICALS : Invited to Present Data at Two Major Upcoming Confe..
04/24 NAVIDEA BIOPHARMACEUTICALS : Macrophage Therapeutics Completes Collaborative stu..
03/31 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
03/29 NAVIDEA BIOPHARMACEUTICALS : reports 4Q loss
03/29 NAVIDEA BIOPHARMACEUTICALS : Provides Corporate Update and Reports Full Year 201..
03/16 NAVIDEA BIOPHARMACEUTICALS : Completes Sale of North American Rights of Lymphose..
03/16 NAVIDEA BIOPHARMACEUTICALS : Research Reports Coverage on Biotech Stocks -- Inot..
03/13 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Departure of Directors..
03/13 NAVIDEA BIOPHARMACEUTICALS, INC. : Change in Directors or Principal Officers (fo..
03/09 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Entry into a Material ..
More news
Sector news : Biotechnology & Medical Research - NEC
04/26 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
04/18DJACTELION : J&J Lifts Forecast on Actelion Tie-Up--Update
04/18DJJOHNSON & JOHNSON : Lifts Forecast on Actelion Tie-Up
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/29 Navidea Biopharm reports Q4 results
03/02 Navidea shareholders OK sale of Lymphoseek sale to Cardinal; shares up 29%
02/23 Navidea settles dispute with debt holder for $59M; shares up 27%
02/23 Navidea trading halted pending news
2016 Navidea sells Lymphoseek to Cardinal Health for up to $310M; shares up 5%
Advertisement
Chart NAVIDEA BIOPHARMACEUTICALS
Duration : Period :
Navidea Biopharmaceuticals Technical Analysis Chart | NAVB | US63937X1037 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Mike M. Goldberg President, Chief Executive Officer & Director
Jed Andrew Latkin Chief Operating & Financial Officer
Frederick O. Cope Chief Scientific Officer & Senior Vice President
Michael Tomblyn Chief Medical Officer & Senior Vice President
David Colborn Vice President-Clinical Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NAVIDEA BIOPHARMACEUTI..-18.27%84
INCYTE CORPORATION22.75%25 180
QUINTILES IMS HOLDINGS..8.68%19 586
LONZA GROUP AG19.57%12 278
CELLTRION, INC.--.--%9 719
SEATTLE GENETICS, INC.26.59%9 546
More Results